Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen -- Ignore unavailable to you. Want to Upgrade?

To: Harold Engstrom who wrote (977)	5/24/1999 12:57:00 PM
From: Beltropolis Boy	Respond to of 1686

quiet here today, thought i'd 'clutter' the board. (sorry, i can't adequately address your amevive question, harold.) ----- The following is a review of the 3 most recent I-Watch reports issued this morning. To view the I-Watch charts and complete coverage, go to thomsoninvest.net BGEN -- Biotechnology -- Healthcare 24-May-99 11:46:31 Biogen is trading higher amidst a sea of red today, up $2 1/2 to $105. Block trading is at moderate levels with 23% of all volume stemming from block trades. The Thomson I-Watch reported trade pie chart shows that institutional brokers have claimed a good portion of today's volume. JP Morgan has booked 150,000 shares while Morgan Stanley has reported 125,000 shares in trades. The block trading levels, as well as modest total trade volume would suggest these brokers are trading largely on behalf of their own house trading accounts, rather than on behalf of institutional investors. Day trading, whether on behalf of professional market makers or retail investors, tends to increase the trading volatility for a stock.